{
  "generated": "2025-11-05T07:22:08.071961+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/psychological/nac-ment-nac-ocd/mental_health/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MENT-NAC-OCD_01",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "ocd",
      "population": "Adults with ocd concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.4088/jcp.16m11101",
      "url": "https://doi.org/10.4088/jcp.16m11101",
      "citation": "MENT-NAC-OCD_01 (2015); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with ocd concerns; Outcome: ocd; DOI: 10.4088/jcp.16m11101; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "MENT-NAC-OCD_02",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "ocd",
      "population": "Adults with ocd concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1016/j.jpsychires.2022.02.038",
      "url": "https://doi.org/10.1016/j.jpsychires.2022.02.038",
      "citation": "MENT-NAC-OCD_02 (2016); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with ocd concerns; Outcome: ocd; DOI: 10.1016/j.jpsychires.2022.02.038; Adverse Events: Transient headache."
    },
    {
      "study_id": "MENT-NAC-OCD_03",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "ocd",
      "population": "Adults with ocd concerns",
      "adverse_events": "None reported",
      "doi": "10.3389/fpsyt.2024.1421150",
      "url": "https://doi.org/10.3389/fpsyt.2024.1421150",
      "citation": "MENT-NAC-OCD_03 (2017); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with ocd concerns; Outcome: ocd; DOI: 10.3389/fpsyt.2024.1421150; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1016/j.jpsychires.2022.02.038",
      "study_ids": [
        "MENT-NAC-OCD_02"
      ],
      "primary_study_id": "MENT-NAC-OCD_02",
      "url": "https://doi.org/10.1016/j.jpsychires.2022.02.038"
    },
    {
      "type": "doi",
      "identifier": "10.3389/fpsyt.2024.1421150",
      "study_ids": [
        "MENT-NAC-OCD_03"
      ],
      "primary_study_id": "MENT-NAC-OCD_03",
      "url": "https://doi.org/10.3389/fpsyt.2024.1421150"
    },
    {
      "type": "doi",
      "identifier": "10.4088/jcp.16m11101",
      "study_ids": [
        "MENT-NAC-OCD_01"
      ],
      "primary_study_id": "MENT-NAC-OCD_01",
      "url": "https://doi.org/10.4088/jcp.16m11101"
    }
  ],
  "manifest_hash": "sha256:dde75209f8717ab8605f8dc7f1e8a17edacca9257115ff1c22f9f1b4747a0db7"
}
